PREVALENCE OF METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAINS AMONG CHINESE PEPTIC-ULCER DISEASE PATIENTS AND NORMAL CONTROLS IN HONG-KONG

Citation
Ck. Ching et al., PREVALENCE OF METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAINS AMONG CHINESE PEPTIC-ULCER DISEASE PATIENTS AND NORMAL CONTROLS IN HONG-KONG, Gut, 38(5), 1996, pp. 675-678
Citations number
23
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
GutACNP
ISSN journal
00175749
Volume
38
Issue
5
Year of publication
1996
Pages
675 - 678
Database
ISI
SICI code
0017-5749(1996)38:5<675:POMHSA>2.0.ZU;2-X
Abstract
Background-A study was conducted to evaluate the prevalence of metroni dazole resistant Helicobacter pylori strains among the Chinese in Hong Kong. The efficacy of the triple therapy that contains metronidazole as one of the anti-microbial agents in eradication of the metronidazol e susceptible and the metronidazole resistant strains was also assesse d. Methods-Culture for H pylori was attempted from antral biopsy speci mens of 70 peptic ulcer and 51 control subjects. Successfully cultured H pylori strains were tested for metronidazole susceptibility. Twenty six peptic ulcer disease subjects who had received a course of triple therapy were also reassessed four to six weeks later for successful e radication of H pylori infection. Results and conclusions-H pylori was successfully cultured from antral biopsy specimens in 69 of 80 (86%) of the infected subjects. The overall metronidazole resistance rate wa s 53.5% (37 of 69). There was a significantly higher metronidazole res istance rate among H pylori isolates from the asymptomatic controls (2 0 of 25) than the peptic ulcer disease subjects (17 of 44) (p=0.0007). Twenty three of 32 (73%) women and 14 of 37 (38%) men harboured the m etronidazole resistant strains. There was no sex or age difference as far as the prevalence of metronidazole resistant strains were concerne d within each study group. Pre-treatment metronidazole susceptible H p ylori were significantly more Likely to respond to the triple therapy used than those with the metronidazole resistant ones (14 of 15 v five of 10) (p=0 021).